title: Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect.
authors.affiliation: Hebrew Hospital Home, Bronx, New York 10475.
authors.forename: W S
authors.initials: WS
authors.lastname: Aronow
authors.forename: C
authors.initials: C
authors.lastname: Ahn
authors.forename: A D
authors.initials: AD
authors.lastname: Mercando
authors.forename: S
authors.initials: S
authors.lastname: Epstein
authors.forename: I
authors.initials: I
authors.lastname: Kronzon
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003327:Coronary Disease / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D011446:Prospective Studies; D016037:Single-Blind Method; D017180:Tachycardia, Ventricular / Q000188:drug therapy / Q000401:mortality*
chemical_list: D011433:Propranolol